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Michellamines A6 (1) and A7 (2) are the ﬁrst dimers of 5,80-coupled naphthylisoquinoline alkaloids with cis-
conﬁgured stereocenters in both tetrahydroisoquinoline subunits. They were isolated from the leaves of
a recently discovered, yet unidentiﬁed Congolese Ancistrocladus liana that shares some morphological
characteristics with Ancistrocladus likoko. Two further new dimeric analogs, michellamines B4 (3) and B5
(4), were obtained, along with two previously likewise unknown monomers, ancistrobonsolines A1 (5) and
A2 (6), which, besides one single known other example, are the only naphthyldihydroisoquinolines with
an M-conﬁgured biaryl axis and R-conﬁguration at C-3. Moreover, ﬁve compounds earlier reported from
other Ancistrocladus species were identiﬁed, ancistroealaine C (7), korupensamines A (8a) and B (8b), and
michellamines A2 (9) and E (10). Their complete structural elucidation succeeded due to the fruitful
interplay of spectroscopic, chemical, and chiroptical methods. Chemotaxonomically, the
stereostructures of the metabolites clearly delineate this Congolese Ancistrocladus liana from all known
related species, showing that it might be a new taxon. Ancistrobonsolines A1 (5) and A2 (6) exhibited
strong preferential cytotoxicities against human PANC-1 pancreatic cancer cells under nutrient-deprived
conditions, without displaying toxicity in normal, nutrient-rich medium. Against cervical HeLa cancer
cells, the dimeric alkaloids michellamines A6 (1) and E (10) displayed the highest cytotoxic activities,
comparable to that of the standard agent, 5-ﬂuorouracil. Furthermore, ancistrobonsolines A1 (5) and A2
(6) showed weak-to-moderate antiprotozoal activities.Introduction
Plants belonging to the genus Ancistrocladus Wall. (Ancis-
trocladaceae) continue to receive much attention, mainly
because they produce a class of structurally, biosynthetically,
and pharmacologically unusual compounds, the naph-
thylisoquinoline alkaloids.1 The genus Ancistrocladus comprisesy of Wu¨rzburg, Am Hubland, D-97074
emie.uni-wuerzburg.de; Fax: +49 931 31
asa, B.P. 202, Kinshasa XI, Democratic
tute, Socinstrasse 57, CH-4002 Basel,
Basel, Switzerland
tute of Natural Medicine, University of
, Japan. E-mail: suresh@inm.u-toyama.
(ESI) available: MS, NMR, CD, and IR
gradation. See DOI: 10.1039/c8ra00363g
hemistry 201818 botanically accepted species of tropical lianas,2–4 of which
four occur in the Democratic Republic of the Congo (DRC),
namely, A. ealaensis J. Le´onard,5 A. congolensis J. Le´onard,5
A. likoko J. Le´onard,5 and A. ileboensis G. Heubl, V. Mudogo &
G. Bringmann.4 The number of Congolese Ancistrocladus
species may, however, be actually much higher, as there have
not yet been thorough and specic botanical campaigns
covering the entire Congolese forest, which is so vast and so rich
in biodiversity. This assumption is also supported by recent
phylogenetic investigations on Ancistrocladus samples collected
at diﬀerent sites in DRC,6 which hinted at the presence of
a potentially new taxon from the region near the village Bon-
solerive, close to the town Mbandaka, in the northwestern part
of DRC.
Most recently, likewise close to the village Bonsolerive, we
have discovered another Ancistrocladus liana. Particularly
striking were its leaves, which were much larger (about 57 cm
long and 12 cm wide) than those of any other Ancistrocladus
plant species found nearby. This liana had hooked inores-
cences, which, together with the aforementioned large size ofRSC Adv., 2018, 8, 5243–5254 | 5243
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View Article Onlinethe leaves, were reminiscent of A. likoko, the only known Con-
golese species with similar – yet diﬀerent – morphological
characteristics.2,5 Comparative LC-UV-MS proling of the leaf
alkaloid pattern of this liana and that of an authentic sample of
A. likoko, however, revealed substantial phytochemical diﬀer-
ences between the two samples. This metabolic divergence and
the fact that A. likoko had so far not been found to occur in that
sampling area indicated that the lianamight belong to a new, as
yet undescribed plant species or subspecies. The isolation and
structural elucidation of its alkaloids thus became a rewarding
task, not only for the chemotaxonomic characterization of this
liana and its possible delineation from other Ancistrocladus
species, but also for their biological evaluation.
Herein we report on the isolation and structural elucidation
of eleven mono- and dimeric naphthylisoquinoline alkaloids
from the leaves of this yet unidentied Ancistrocladus liana
(Fig. 1). The isolated metabolites comprise six previously
unknown compounds: michellamines A6 (1), A7 (2), B4 (3), and
B5 (4), ancistrobonsoline A1 (5) and its 6-O-methyl derivative,
ancistrobonsoline A2 (6), and ve analogs described from earlier
work on other Ancistrocladus plants: ancistroealaine C (7),7Fig. 1 Metabolites isolated from an as yet unidentiﬁed Congolese Ancist
A7 (2), B4 (3), and B5 (4), ancistrobonsolines A1 (5) and A2 (6), and ﬁve prev
(8b), and michellamines A2 (9) and E (10). Yellow ellipses on 1 and 2 high
any other related dimer; for reason of comparison, see the structure of
(underlaid in gray) in both molecular halves – this compound is not pro
5244 | RSC Adv., 2018, 8, 5243–5254korupensamines A (8a) and B (8b),8 and michellamines A2 (9)9
and E (10).10 Furthermore, we discuss the chemotaxonomic
position of this liana relative to other Ancistrocladus species. The
cytotoxic activities of the isolated compounds against cervical
HeLa cancer cells and their antiausterity potencies against
PANC-1 human pancreatic cancer cells are also described, as
well as the antiprotozoal properties of the new monomeric
compounds.Results and discussion
Isolation and structural elucidation of metabolites
Identication of the known compounds 7–10. Extraction of
the air-dried leaves with a mixture of methanol and dichloro-
methane (1 : 1), followed by concentration under reduced
pressure, provided a crude residue, which was then submitted
to a cation-exchange column to remove undesired, non-basic
metabolites. The resulting alkaloid-enriched fraction was par-
titioned between water and dichloromethane, and monitored
by HPLC (Fig. 2).rocladus liana, among them six new compounds: michellamines A6 (1),
iously known ones: ancistroealaine C (7), korupensamines A (8a) and B
light the combination of two 1,3-cis-conﬁgurations, never observed in
the well-known michellamine A (11) with its 1,3-trans-conﬁgurations
duced by the investigated Congolese liana.
This journal is © The Royal Society of Chemistry 2018
Fig. 2 HPLC proﬁles of the alkaloid-enriched subfractions from the
leaves of the plant.
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
1 
Ja
nu
ar
y 
20
18
. D
ow
nl
oa
de
d 
on
 2
2/
02
/2
01
8 
12
:5
4:
43
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineResolution of the water-phase subfraction on a preparative
HPLC column permitted isolation of nine pure constituents,
obtained as amorphous solids. The fastest-eluting compound
(Peak A, Fig. 2a) was found to be ancistroealaine C (7), earlier
known from Ancistrocladus ealaensis.7 The second alkaloid (Peak
B) was korupensamine A (8a), while peak C contained two
alkaloids overlapping each other, korupensamine B (8b) and
michellamine A2 (9), and peak G was michellamine E (10).
These four metabolites (8a/b–10) had previously been isolated
from other Ancistrocladus species, yet only from Central Africa:
The korupensamines A (8a) and B (8b), rst known from theTable 1 1H and 13C NMR data of michellamine A6 (1), and of ancistrobo
Position
1b 5
dH dC dH
1 4.64, q (6.5) 52.4
3 3.27, m 51.0 3.70, m
4eq. 2.64, dd (3.3, 17.3) 33.3 2.41, dd (
4ax 2.27, dd (12.0, 17.3) 33.3 2.48, dd (
5 119.4
6 156.8
7 6.47, s 102.9 6.67, s
8 156.5
9 113.0
10 135.2
10 6.84, pt (0.9) 119.3 6.72, pt (1
20 137.7
30 6.86, pd (1.3) 108.1 6.83, pd (
40 158.2
50 152.4
60 120.4 6.80, d (7
70 7.29, s 134.9 7.05, d (7
80 124.3
90 137.1
100 115.3
1-Me 1.82, d (6.5) 20.0 2.79, pd (
3-Me 1.26, d (6.5) 18.9 1.26, d (6
20-Me 2.37, s 22.3 2.34, pd (
6-OMe
8-OMe 4.04, s
40-OMe 4.10, s 57.1 4.10, s
a 1H and 13C NMR data were recorded inmethanol-d4 (d in ppm).
b These d
1.
This journal is © The Royal Society of Chemistry 2018Cameroonian plant A. korupensis8 as well as michellamine E
(10),10 had both also been reported from A. likoko,11,12where they
occur as major metabolites. Korupensamine A (8a) is likewise
the main naphthylisoquinoline alkaloid in A. congolensis,9,13 in
which michellamine A2 (9) was discovered9 before its more
recent detection as a minor constituent of A. likoko.12 The other
four remaining compounds from the aqueous subfraction
(Peaks D, E, F, and H, Fig. 2a), as well as those from the
dichloromethane subfraction (Peaks I and J, Fig. 2b), were as yet
unknown.
Michellamine A6 (1). The rst new metabolite, compound 1
(Peak D, Fig. 2a), had a molecular formula C46H48N2O8, as evi-
denced from HRESIMS (757.3486, [M + H]+). 1H and 13C NMR
measurements showed only a half set of signals, which indi-
cated that this metabolite consisted of two equivalent molecular
portions, but le open the question of whether the two halves
were homomorphous or enantiomorphous to each other. The
latter possibility (i.e., the presence of an achiral meso
compound) was excluded by its optical activity, showing that 1
was C2-symmetric.
The 1H NMR spectrum (Table 1) exhibited four aromatic
protons. Two of them displayed a meta-coupling, typical of
protons at C-10 and C-30,7–10 while the other two appeared as
singlets, which suggested the presence of a symmetric dimer of
5,60-, 5,80-, 7,60-, or 7,80-coupled naphthylisoquinoline mono-
mers. The aliphatic region, with two three-proton doublets (Me-nsolines A1 (5) and A2 (6)
a
6
dC dH dC
175.8 176.3
49.5 3.71, m 49.6
5.8, 16.9) 33.6 2.42, dd (5.8, 16.9) 33.4
11.3, 16.9) 33.6 2.49, dd (11.3, 16.9) 33.4
122.5 123.6
167.8 168.7
99.3 6.83, s 95.9
165.8 166.4
108.8 109.2
142.9 141.6
.1) 118.7 6.64, pt (1.1) 118.6
138.2 138.2
0.9) 107.9 6.82, pd (0.9) 107.8
158.2 158.1
156.4 156.2
.9) 110.4 6.78, d (7.9) 110.3
.9) 131.7 7.00, d (7.9) 131.4
123.1 123.3
136.7 136.6
115.0 114.8
1.5) 24.8 2.82, pd (1.5) 24.9
.6) 18.2 1.27, d (6.6) 18.1
0.6) 22.3 2.32, pd (0.8) 22.3
3.83, s 57.2
56.8 4.15, s 57.0
57.0 4.10, s 57.0
ata are identical for the secondmolecular half of the C2-symmetric dimer
RSC Adv., 2018, 8, 5243–5254 | 5245
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View Article Online1 and Me-3), signals for two aryl substituents (a methyl group
and amethoxy function), a quartet, a multiplet, and two doublet
of doublets, was, however, closely similar to that of the likewise
isolated known ancistroealaine C (7), so that a 5,80-coupled
molecular framework was expected. In agreement with this
assumption, one of the two aromatic singlets was assigned as H-
7, from its HMBC correlations with C-6, C-8, and C-9 (Fig. 3a).
This showed that the other, remaining singlet had to be at C-70
and, hence, clearly excluded any biaryl linkage involving C-7.
The two remaining possible coupling types (5,60 or 5,80) were
further discriminated by joint correlative HMBC signals fromH-
7 and H-10 to C-80 (Fig. 3a), which excluded a 5,60-coupling,
where such interactions would not have been observed. Thus,
the naphthalene and isoquinoline portions were linked to each
other by a 5,80-axis, and the two monomeric naph-
thylisoquinoline halves were therefore connected via C-60. These
couplings, in particular the 60,600-linkage between the naph-
thalene portions, were further corroborated by the chemical
shis of C-60 (dC 120.4) and of the surrounding nuclei, C-50 (dC
152.4) and C-70 (dC 134.9), which were near-identical to those of
other dimers with similar molecular frameworks (e.g.,
michellamine A2 (9):9 dC 120.3 for C-60, 152.3 for C-50, and 134.7
for C-70). The location of the methoxy group at C-40 was deduced
from NOE interactions of its protons with H-30, in conjunction
with joint HMBC correlations from both the O-methyl protons
and H-30 to C-40 (Fig. 3a).
Based on NOESY interactions of the proton at C-3 and the
one at C-1 (Fig. 3a), the relative conguration at the stereo-
centers C-1 and C-3 was determined to be cis. Ruthenium-Fig. 3 (a) Key HMBC (red single arrows) and ROESY (blue double
arrows) interactions evidencing the constitution of the homodimer 1.
(b) ROESY interactions indicating the relative and – given the results of
oxidative degradation – absolute conﬁgurations of the two identical
portions (¼ancistroealaine C, 7) of 1.
5246 | RSC Adv., 2018, 8, 5243–5254mediated oxidative degradation14 of this alkaloid led to the R-
enantiomer of 3-aminobutyric acid (derived from C-3), as
monitored by GC-MSD analysis of the Mosher derivatives. This
revealed C-3 to be R-congured and, given the aforementioned
relative cis-conguration, C-1 had to be S-congured.
At the naphthalene-isoquinoline biaryl axes, within the 5,80-
coupled monomeric halves, the stereo-array was determined by
NOESY interactions of the proton at C-70 with the equatorial
proton at C-4 (dH ¼ 2.64 ppm; J ¼ 17.3, 3.3 Hz) and between the
axial proton (dH¼ 2.27 ppm; J¼ 17.3, 12.0 Hz) and the aromatic
proton at C-10. This, in conjunction with the absolute R-
conguration at C-3, as depicted in Fig. 3b, indicated P-
conguration at the outer axes, revealing these portions to be
structurally identical to the co-occurring known ancistroealaine
C (7). Hence, the metabolite was found to be the 60-homocou-
pling product of 7, with the absolute stereostructure 1 presented
in Fig. 1. This was further conrmed by the similarity of the
ECD (electronic circular dichroism) spectrum of 1 with that of
the co-occurring, likewise P,P-congured michellamine A2 (9).
Owing to this combination of two P-congured outer biaryl axes,
the new compound was included in the ‘series A’ of michell-
amines – which so far comprised michellamines A–A5 – and was
thus named michellamine A6. Its 1,3-cis-congurations in both
tetrahydroisoquinoline portions, as highlighted in Fig. 1, is
a unique structural feature that had not been found in any other
similarly coupled naphthylisoquinoline dimers.
Michellamine A7 (2). The second new alkaloid, compound 2,
corresponding to peak E in Fig. 2a, had a molecular weight 14
units larger than that of 1, matching with themolecular formula
C47H50N2O8 (m/z 771.3655, HRESIMS). Its UV spectrum, which
was very similar to that of 1, indicated that 2 was a 60,600-coupled
dimer, too. This was further supported by its 1H NMR spectrum
(Table 2), which closely resembled that of the co-isolated
michellamine A2 (9), except for the presence of one additional
three-proton singlet at 3.04 ppm. In the HSQC experiment, this
extra methyl signal correlated with the carbon atom at
41.4 ppm, thus indicating 2 to be an N-methylated
michellamine-type dimer.
Further 1D and 2D NMR data revealed that methyl group to
be attached to the nitrogen atom in the ‘southeastern’ portion.
Key evidence of the exact location of this N-methyl group were
the HMBC correlations of its protons with both, C-1 and C-3
(Fig. 4a) and the signals of these methine carbons, which
appeared deshielded (62.6 ppm for C-1 and 60.6 for C-3) as
compared to those of the N-demethylated congeners – like, for
example, in the case of 1 (Tables 1 and 2). This assignment was
further supported by the ROESY series {Me-14 N–Me4 Me-
3}, which, in addition, revealed a 1,3-diaxial relationship of H-
1 and H-3 and, thus, a relative cis-conguration at the stereo-
centers C-1 and C-3 (Fig. 4a). For the stereocenters in the other,
‘northwestern’ part of 2, a relative cis-conguration was
observed, too, again evidenced by the ROESY interactions of H-
1000 with H-3000, as in 1 (Fig. 3b).
The ruthenium-mediated oxidative degradation of 2 yielded
both, R- and S-congured 3-aminobutyric acids, showing that
this alkaloid was either 3R,3000S- or 3S,3000R-congured. The
simultaneous formation of the N-methylated analog of 3-This journal is © The Royal Society of Chemistry 2018
Table 2 1H and 13C NMR data of michellamines A7 (2), B4 (3), and B5 (4)
a
Position
2 3 4
dH dC dH dC dH dC
1/1000 4.64, q (6.6)/4.64, q (6.6) 62.6/52.5 4.74, q (6.7)/4.64, q (6.5) 49.5/52.4 —/4.64, q (6.6) 175.8/52.4
3/3000 3.23, m/3.29, m 60.6/51.0 3.66, m/3.29, m 45.4/50.9 3.72, m/3.29, m 49.4/50.9
4eq./4000eq. 2.36b, dd/2.65,
dd (4.3, 17.8)
34.5/33.4 2.37b, dd/2.61,
dd (3.3, 17.4)
34.1/33.3 2.52, ddc/2.59, ddc 33.6/33.3
4ax/4000ax 2.69, dd (11.4; 18.0)/2.28,
dd (12.2, 17.8)
2.53, dd (11.7; 18.1)/2.26,
dd (12.0, 17.4)
2.61, ddc/2.25, dd (11.9, 17.2)
5/5000 119.1/119.4 119.1/119.2 122.3/119.2
6/6000 157.0/156.8 157.0/156.8 167.8/156.8
7/7000 6.47, s/6.47, s 102.6/102.9 6.46, s/6.48, s 102.2/102.9 6.69, s/6.48, s 99.4/102.9
8/8000 155.7/156.5 155.7/156.5 165.8/156.5
9/9000 113.4/113.0 113.4/113.0 108.8/113.0
10/10000 135.2/135.2 133.2/135.2 143.0/135.2
10/100 6.78, s/6.85, s 119.5/119.4 6.84, s/6.84, s 119.4/119.3 6.77, pt (1.2)/6.84, pt (1.2) 118.9/119.4
20/200 137.6/137.7 137.8/137.8 138.2/137.8
30/300 6.87, s/6.86, s 108.2/108.1 6.87, s/6.87, s 108.3/108.1 6.88, d (1.2)/6.86, d (1.4) 108.3/108.1
40/4000 158.3/158.2 158.2/158.2 158.2/158.3
50/500 152.5/152.4 152.4/152.4 152.5/152.9
60/600 120.4/120.4 120.3/120.3 120.0/120.4
70/700 7.33, s/7.29, s 135.7/135.0 7.27, s/7.30, s 135.3/134.9 7.30, s/7.30, s 135.2/134.9
80/800 124.0/124.3 124.3/124.3 122.6/124.3
90/900 136.5/137.1 136.6/137.2 136.1/137.2
100/1000 115.2/115.3 115.4/115.3 115.2/115.3
1-Me/1000-Me 1.77, d (6.7)/1.82, d (6.6) 19.6/20.0 1.70, d (6.7)/1.82, d (6.5) 18.5/20.0 2.77, d (1.4)/1.82, d (6.6) 24.9/20.0
3-Me/3000-Me 1.33, d (6.6)/1.27, d (6.5) 18.2/18.9 1.28, d (6.3)/1.24, d (6.4) 19.4/18.9 1.28, d (6.7)/1.24, d (6.5) 18.2/18.9
20-Me/200-Me 2.36, s/2.37, s 22.3/22.3 2.37, s/2.37, s 22.3/22.3 2.37, s/2.37, s 22.3/22.3
8-OMe 4.03, s 56.8
40-OMe/400-OMe 4.12, s/4.10, s 57.1/57.1 4.11, s/4.11, s 57.2/57.2 4.11, s/4.10, s 57.1/57.2
N-Me 3.04, s 41.4
a The NMR data were recorded in methanol-d4 (d in ppm).
b This signal was overlapped by that of 20-Me, but could be deduced to be dd, from the
respective 2D NMR cross peaks. c These signals overlapped each other.
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View Article Onlineaminobutyric acid only as its S-enantiomer, however, clearly
indicated that the S-congured stereocenter was located next to
the N-methyl group, i.e. at C-3. Thus, this compound was found
to be 3S,3000R-congured, which, given the relative cis-congu-
rations in both halves as mentioned above, showed that C-1 and
C-1000 were R- and S-congured, respectively.
From ROESY interactions between H-4ax and H-70 and
between H-4eq. and H-10 (Fig. 4a), and based on the above-
assigned S-conguration at C-3, the conguration at the
southeastern axis was determined to be P, thus revealing this
portion to correspond to korupensamine D, a known naph-
thylisoquinoline alkaloid from A. korupensis (for its structure,
see Fig. S1†).8 At the other, northwestern axis of 2, the ROESY
interactions were complementary: H-4000ax with H-100 and H-4000eq.
with H-700, which, together with the opposite R-conguration at
C-3000 established above, indicated that axis to be P-congured,
too, as in 1 (Fig. 3b). This metabolite thus had to be a cross-
coupling product of ancistroealaine C (7) and korupensamine
D (Fig. S1†),8 and possessed the absolute structure 2 presented
in Fig. 1. It was named michellamine A7, due to its P,P-cong-
ured outer biaryl axes, as in 1. It is the second dimer of 5,80-
coupled naphthylisoquinolines with the unusual combination
of two 1,3-cis-congured halves.This journal is © The Royal Society of Chemistry 2018Michellamine B4 (3). Compound 3, with a slightly longer
retention time than those of 1 and 2 (Peak F, Fig. 2a), was
revealed to be isomeric to 1 by mass spectrometry (HRESIMS:m/
z 757.3475 [M + H]+, molecular formula: C46H48N2O8). Both, its
1H and 13C NMR spectra (Table 2) displayed full sets of signals,
which showed that, diﬀerent from 1, it consisted of two non-
identical molecular halves.
The 1H NMR spectrum of 1matched the half-set of signals of
3 nearly perfectly (DdH # 0.02, see Tables 1 and 2), which sug-
gested that the two compounds had one molecular portion in
common. Further analysis of the 1D and 2D NMR data of 3
established the constitution of 3 to be identical to that of 1, that
is, two 5,80-coupled naphthylisoquinoline halves connected to
each other via C-60 (Fig. 3a).
In one portion, the northwestern part of 3, the relative
conguration at the stereocenters C-1000 versus C-3000 was deduced
to be cis from ROE interactions of H-1000 and H-3000, as also (even
twice) in 1 (Fig. 3b). In the southeastern part of 3, however, the
stereocenters were trans-congured, as evidenced from ROESY
interactions between H-3 and Me-1 (Fig. 4b). The ruthenium-
mediated oxidative degradation of 3 yielded 3-aminobutyric
acid as its R-enantiomer exclusively, which demonstrated that
both, C-3 and C-3000 were R-congured. This, together with theRSC Adv., 2018, 8, 5243–5254 | 5247
Fig. 4 (a) Selected HMBC (red single arrows) and ROESY (blue double
arrows) interactions within the ‘southeastern’ portion of 2 establishing
its constitution and – together with the results of the oxidative
degradation– absolute conﬁguration (¼korupensamine D, Fig. S1†). (b)
ROESY correlations evidencing the relative and – based on the results
of the oxidative degradation – absolute conﬁgurations in the south-
eastern part (¼korupensamine B, 8a) of 3. (c) Key HMBC and ROESY for
the ‘southeastern’ portion of 4 that, together with the results of the
oxidative degradation, establish the absolute stereostructure of this
portion (¼the new compound ancistrobonsoline A1, 5).
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View Article Onlineaforementioned cis- and trans-arrays, established the absolute
congurations at C-1000 and C-1 to be S and R, respectively.
From ROESY interactions of H-4000ax with H-100 and of H-4000eq.
with H-700 and in view of the absolute R-conguration at C-3000,
the absolute axial conguration in the northwestern half was
assigned to be P, revealing this portion to be identical to 7, as in
1 (Fig. 3b). In the other, southeastern part, the respective
protons interacted in a complementary way: H-4ax with H-70 and
H-4eq. with H-10, as shown in Fig. 4b. These correlations,
together with the known R-conguration at C-3 (see above),
evidenced the southeastern biaryl axis to be M-congured, thus
showing the corresponding moiety to have the same structure
as the likewise isolated korupensamine B (8b) (Fig. 4b). There-
fore, compound 3 had to be the 60,600-cross-coupling product of
ancistroealaine C (7) and korupensamine B (8b), with the
absolute stereostructure given in Fig. 1. It was named michell-
amine B4, in continuation of the series of michellamines with
opposite congurations at the two outer biaryl axes (type B).
Michellamine B5 (4). Compound 4, the slowest-eluting major
metabolite of the aqueous fraction (Peak H, Fig. 2a), gave
amonoprotonatedmolecule atm/z 769.3484 in HRESIMS, i.e. 12
units more than that of 3. Its 1H NMR spectrum displayed a full
set of signals, with in particular one quartet (instead of two),
thus indicating that this metabolite consisted of a naphthyl-1,3-5248 | RSC Adv., 2018, 8, 5243–5254dimethyltetrahydro- and a naphthyl-1,3-
dimethyldihydroisoquinoline subunit. In addition, this dimer
had three methoxy functions (4.11, 4.10, and 4.03 ppm), i.e. one
O-methyl group more than the other three compounds, 1–3.
Comparison of its 1H NMR spectrum with those of 1–3 showed
that these four metabolites had one common, nearly perfectly
matching half-set of signals, corresponding to the northwestern
portions of 1–3, which were equivalent to ancistroealaine C (7).
The northwestern portion of 4 was therefore expected to be
identical to 7, too, and its southeastern part was assumed to be
the naphthyl-1,3-dimethyldihydroisoquinoline moiety, pos-
sessing two methoxy groups.
This assumption was corroborated by 1D and 2D NMR data,
which led to a molecular architecture similar to that of 3, but
with one additional methyl group attached to the oxygen func-
tion at C-8 and a double bond between C-1 and the adjacent
nitrogen atom in the southeastern portion (Fig. 4c). Key NMR
features of the location of the methoxy function at C-8 were the
joint HMBC interactions from H-7 and OMe-8 to C-8 and the
ROESY series {H-74 OMe-84 Me-1} (Fig. 4c).
The oxidative degradation procedure delivered only (R)-3-
aminobutyric acid, showing that both, C-3 and C-3000 were R-
congured. In the northwestern portion, ROESY interactions at
the stereocenters C-1000 versus C-3000 and across the naphthalene–
isoquinoline linkage were the same as in 1 (Fig. 3b), so that C-1
was S-congured and the biaryl axis had the P-conguration. In
the southeastern portion, the ROESY interaction between H-4ax
and H-70 indicated these two spin systems to be on the same
side of the molecule, as depicted in Fig. 4c, which evidenced an
M-conguration at the biaryl axis. Therefore, this metabolite
possessed the absolute stereostructure 4, as shown in Fig. 1. It
was named michellamine B5, due to its stereochemical simi-
larity with michellamine B4 (3). Within a list of now 16 known
natural michellamine-type dimers, it is only the third example
that possesses a dihydroisoquinoline ring system; the other two
analogs with such a structural peculiarity are michellamines F10
and A4.9
Ancistrobonsoline A1 (5). The dichloromethane subfraction
contained two major, nicely resolved metabolites (Fig. 2b). They
were obtained as amorphous solids by resolution on a prepara-
tive reverse-phase HPLC column. The more polar one (Peak J,
Fig. 2b), compound 5, gave an m/z at 392.1843 [M + H]+, corre-
sponding to the molecular formula C24H25NO4. In the
1H NMR
spectrum, the presence of two methoxy signals, together with
the absence of a quartet around 4.5 ppm, which typically indi-
cates a proton located at C-1, hinted at a naphthyl-1,3-
dimethyldihydroisoquinoline alkaloid, presumably equivalent
to the southeastern portion of 4. This was further corroborated
by the fact that the signals in the aliphatic region of the 1H NMR
spectrum of 5 matched very well with those assigned to the
protons of the southeastern half of 4. Detailed analysis of the 1D
and 2D NMR spectra of this monomeric alkaloid established it
to have the same molecular skeleton as the southeastern
portion of 4, yet with an additional proton at C-60.
The ROESY interactions across the biaryl axis of 5 were all
similar to those in the southeastern portion of 4 (see Fig. 4c), as
were also the results of the oxidative degradation. ThisThis journal is © The Royal Society of Chemistry 2018
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View Article Onlinemonomeric alkaloid thus possessed the absolute stereo-
structure 5, as presented in Fig. 1. It was, consequently, the as
yet undescribed enantiomer of the known alkaloid 6,50-O,O-
didemethylancistroealaine A.15 In agreement with their oppo-
site absolute congurations, their ECD spectra were fully
mirror-image like (Fig. 5). Instead of the rational, but long name
ent-6,50-O,O-didemethylancistroealaine A, the new compound
was named ancistrobonsoline A1, aer the Congolese village
Bonsolerive, where the plant had been collected.
Ancistrobonsoline A2 (6). The sixth new compound discov-
ered during these investigations (Peak I, Fig. 2b) was attributed
the molecular formula C25H27NO4 according to the observation
of its mono-protonated molecule at m/z 406.2013 in HRESIMS.
Its 1H NMR spectrumwas very similar to that of 5, indicating the
presence of a 1,3-dimethyldihydroisoquinoline, yet with the
signal of an additional O-methyl group at 3.83 ppm, linked
either to O-6 or O-50. NOE interactions of the protons of that O-
methyl group with H-7, together with their joint HMBC corre-
lations to C-6, clearly located that methoxy function at C-6.
The absolute conguration at the stereocenter C-3 of 6 was
determined to be R by oxidative degradation, which, as in the
case of 5, provided (R)-3-aminobutyric acid. Across the biaryl
axis the specic relationships between the diastereotopic
protons at C-4 and the aromatic protons H-10 and H-70 were the
same as in 5 (Fig. 4c): H-4ax (‘up’) interacted with H-70 and H-4eq.
(‘down’) with H-10, which was consistent with an M-congura-
tion at the 5,80-axis. This absolute stereochemical assignment
was further corroborated by the close similarity of the ECD
spectrum of 6 with that of 5. Therefore, the new alkaloid had to
possess the absolute stereostructure 6, as presented in Fig. 1,
and was, thus, the 6-O-methylated derivative of 5. It was named
ancistrobonsoline A2. With their R-conguration at the stereo-
center andM at the biaryl axis, ancistrobonsolines A1 (5) and A2Fig. 5 Comparison of the ECD spectrum of 5with that of its previously
known natural enantiomer, ent-5 (¼6,50-O,O-didemethylancis-
troealaine A),15 further conﬁrming the absolute stereostructure of 5.
This journal is © The Royal Society of Chemistry 2018(6) belong to a very small subgroup of naphthyldihy-
droisoquinolines displaying such stereochemical features, with
previously only one single representative, ancistrolikokine F
(Fig. S1†).12Chemotaxonomic and biosynthetic signicance of the
isolated metabolites
The molecular architectures of the alkaloids thus isolated from
this as yet unidentied Ancistrocladus taxon are remarkable in
many respects. Firstly, it is striking that all of these compounds
belong to the same 5,80-coupling type and, where dimers are
concerned, they are all based on a central 60,600-axis. Such
a specic phenol-oxidative coupling – and, thus strict enzymic
assistance – have so far been observed only in A. likoko.11,12,16
These ndings thus reveal a close phylogenetic relationship
between the two taxa (in addition to their aforementioned
morphological similarities), but delineate one from the other by
the fact that the naphthalene moieties of the metabolites
produced by the plant from the proximity of Bonsolerive are, all
of them, O-methylated only at C-40 (and C-400, in the case of
dimers), not at C-50 (nor at C-500). And their conguration at C-3
(or/and C-3000, for dimeric compounds) is always R, except for the
N-methylated isoquinoline portions, where an exclusive S-
conguration is observed (see Fig. 1). Such a regioselective O-
methylation in the naphthalene subunits and a stereospecicity
at C-3 (and/or C-3000) are not known from A. likoko (or from any
other related plant). Likewise demarcating these two taxa is the
fact that A. likoko is a virtually exclusive producer of monomeric
alkaloids (out of 21 metabolites, only two dimers have so far
been isolated from this species),12 whereas the plant investi-
gated here is a rich source of dimeric compounds.
Moreover, the remarkable occurrence of dimers with
a symmetric 60,600-coupling at the central axis chemotaxonomi-
cally delineates this taxon from the other – likewise still
unidentied – liana that occurs in the same area.6 The latter is
known to produce a drastically diﬀerent metabolic pattern,
including dimers with unsymmetric, 60,100-coupled central
axes,17 with additional oxygen bridges18 and/or acetal linkages,21
but so far no symmetric, 60,600-coupled ones, not even in traces.
Secondly, it is particularly noteworthy that this liana
produces the 1,3-trans-congured korupensamine A (8a) only in
small quantities (Peak B, Fig. 2a) and shows no hints at the
presence of its dimer, michellamine A (11), not even in traces.20
This is exceptional, since all of the plants known to produce
michellamine-type alkaloids, viz. A. korupensis,10,20 A. congolesis,9
and A. likoko,12 always contain michellamine A (11) as one of the
main dimeric compounds. Moreover, 11 is always accompanied
by its monomer, korupensamine A (8a), likewise occurring as
a major metabolite in those plants.9,10,20 For this reason, it has
even been suggested9 that other (minor) dimeric analogs
diﬀering from michellamine A (11) by the congurations at the
stereocenters may originate from the preformed ‘parent’ dimer
michellamine A (11), i.e. by modication aer the dimerization
step. In the case of the metabolites of the plant investigated
here, however, one of the main constituents (Peak D, Fig. 2a),
michellamine A6 (1), is twofold 1,3-cis-congured and can beRSC Adv., 2018, 8, 5243–5254 | 5249
Table 4 Growth-inhibitory activities of the isolated compounds 1–10
against HeLa cervical cancer cells (IC50) and, following the antiausterity
strategy, against the human PANC-1 pancreatic cancer cell line (PC50)
Compound HeLa (IC50 in mM) PANC-1
a (PC50 in mM)
1 14.8 54.2
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View Article Onlineregarded as a bis-epimer of michellamine A (11) at C-1 and C-1000.
Since 1 is accompanied by an unusually large quantity of its –
likewise cis-congured – monomer (Peak A, Fig. 2a), ancis-
troealaine C (¼1-epi-korupensamine A) (7), it seems likely that 1
(as also 2) originates from the correspondingly preformed cis-
monomers.2 20.6 24.3
3 46.3 50.3
4 29.8 60.2
5 14.3 7.5
6 21.5 12.1
7 30.5 >100
8a 48.3 >100
8b 37.8 94.9
9 32.1 19.3
10 8.8 18.9
Standard 13.9b 0.8c
a Concentration at which 50% of the PANC-1 pancreatic cancer cells
were killed preferentially in nutrient-deprived medium (NDM). b 5-
Fluorouracil. c Arctigenin.Biological activities of the isolated metabolites
Antiprotozoal properties. Owing to the pronounced anti-
protozoal activities of some naphthylisoquinoline alka-
loids,1,19,21–23 the two new monomers ancistrobonsolines A1 (5)
and A2 (6) were tested against the pathogens causing malaria
(Plasmodium falciparum), human African sleeping sickness
(Trypanosoma brucei rhodesiense), Chagas' disease (T. cruzi), and
visceral leishmaniosis (Leishmania donovani). The other isolated
new dimeric metabolites were not evaluated, since their analogs
had previously been found inactive.8,10 As shown in Table 3,
compounds 5 and 6 exhibited weak to moderate inhibitory
properties. Of particular interest is that the results of 5 and 6
showed the OMe/OH substitution pattern to play a crucial role
for the bioactivities: an O-methylation seems to be favorable for
the antiplasmodial and antitrypanosomal activities, but disad-
vantageous for the antileishmanial activity. This nding
complements previous results on the antileishmanial activities
of related alkaloids, yet with P-conguration at the axis and S at
C-3.15 Likewise interesting are the antiprotozoal activities of 5
and its enantiomer (Table 3), which are – in the case of T. cruzi –
drastically diﬀerent from one to another, documenting, once
again, the impact of the absolute stereostructure.
Anti-HeLa potential: cytotoxicity and eﬀects on cell
morphology. As part of our ongoing investigations on the
potential of naphthylisoquinoline alkaloids towards diﬀerent
cancer cell lines,12,24–26 the isolated compounds were tested for
their cytotoxic activity against HeLa human cervical cancer cells
(Table 4). Interestingly, the new twofold 1,3-cis-congured
dimeric compounds, michellamines A6 (1) and A7 (2), and the
likewise new naphthyldihydroisoquinoline alkaloids, ancis-
trobonsolines A1 (5) and A2 (6), displayed strong cytotoxic
activity, with IC50 values between 14.8 and 21.5 mM. The most
potent cytotoxicity (IC50 ¼ 8.8 mM) was displayed by michell-
amine E (10), which was even more active than the positiveTable 3 Antiprotozoal activities of the new naphthyldihydroisoquinoline
5 (ref. 15)
Compound
IC50 (mM)
P. falciparum
T. brucei
rhodesiense STIB900
T. cru
TulahK1 NF54
5 2.7 2.1 44.4 109.3
ent-5a 5.4 n. d 24.8 16.3
6 1.8 2.4 12.6 80.1
Standard 0.31b 0.01b 0.04c 5.69
a Values reported earlier (see, ref. 15). b Chloroquine. c Melarsoprol. d Ben
5250 | RSC Adv., 2018, 8, 5243–5254control 5-uorouracil (IC50 ¼ 13.9 mM), an anticancer drug in
clinical use.27
Michellamine E (10) was, therefore, investigated for its
eﬀects on cell morphology and apoptosis using two distinct
stainingmethods, the Hoechst 33342 staining and the ethidium
bromide–acridine orange (EB–AO) double staining assay. In the
Hoechst 33342 staining, the dye penetrates through the cell
membrane and intercalates with DNA and emits blue uores-
cence.28 As shown in Fig. 6a, untreated HeLa cells (the control)
displayed regular cell morphology with the intact nuclei.
However, treatment with 12.5 mM of 10 induced nuclear frag-
mentation, suggestive of cells undergoing apoptosis, as indi-
cated by fragmented nuclei exemplarily shown by white arrows
in Fig. 6a. The EB–AO assay, on the other hand, allows visual-
izing the cellular morphology as well as the distinction between
the live and dead cells. Acridine orange (AO) is a cell-membrane
permeable dye emitting bright-green uorescence in live cells,
and ethidium bromide (EB) penetrates only the membrane of
dying or dead cells staining them red.29 As shown in Fig. 6b,
untreated HeLa cells (the control) displayed intact, regular cell
morphology with exclusive bright green uorescence in AO–EBalkaloids 5 and 6, and the previously reported data of the enantiomer of
zi
uen C2C4 Lac Z
L. donovani axenic amastigotes
MHOM/ET/67/L82
Cytotoxicity
(L6 cells)
87.9 114.9
43.4 >230
246.6 52.8
d 1.08e 0.01f
znidazole. e Miltefosine. f Podophyllotoxin.
This journal is © The Royal Society of Chemistry 2018
Fig. 6 Morphological changes of HeLa human cervical cancer cells induced by 12.5 mM of michellamine E (10) in comparison to untreated
control: (a) Hoechst 33342 nuclei staining and (b) acridine orange (AO) – ethidium bromide (EB) staining.
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View Article Onlinestaining. Treatment of the tumor cells with 12.5 mM of 10,
however, disrupted the cellular integrity leading to rounding of
the cell membrane, membrane rupture, and disintegration of
cellular contents resulting in an increased population of red EB
uorescence of dead cells (Fig. 6b).
Antiausterity activities: preferential cytotoxicity against
PANC-1 human cancer cell line and eﬀects on cell morphology.
Following the antiausterity strategy as recently developed,30–32
the isolated naphthylisoquinoline alkaloids 1–10 were tested
against PANC-1 pancreatic cancer cells. Pancreatic tumors are
hypovascular (limited blood vessels) in nature and are, conse-
quently, constantly exposed to nutrient and oxygen starvation in
their microenvironment. However, pancreatic cancer cells show
a remarkable tolerance for nutrition starvation, allowing them
to adapt and survive in such inadequate supply of nutrients.30
Discovery of anticancer agents by targeting this tolerance of
nutrition starvation is the key approach of antiausterity strategy
in anticancer drug discovery. The new dimer michellamine A7
(2) and its known analogs michellamines A2 (9) and E (10)
exhibited signicant preferential cytotoxicities against PANC-1Fig. 7 Morphological changes of PANC-1 human pancreatic cancer cells
comparison to the untreated ones (control).
This journal is © The Royal Society of Chemistry 2018cells in a concentration-dependent manner (Fig. S2†). Their
PC50 values (i.e. the concentration at which 50% of the cells are
preferentially killed under nutrient-deprived conditions,
without cytotoxicity in normal, nutrient-rich medium) ranged
from 18.9 to 24.3 mM, but were surpassed by the even higher
activities of the new monomeric compounds ancistrobonso-
lines A1 (5) and A2 (6), with PC50 values of 7.5 and 12.1 mM,
respectively (Table 4).
The eﬀects of ancistrobonsolines A1 (5) and A2 (6), as
representatives of the compounds showing potent antiausterity
activities, on the cell morphology and apoptosis were further
investigated by the ethidium bromide (EB) – acridine orange
(AO) double-staining uorescence assay as described above. As
shown in Fig. 7(A and A0), the untreated PANC-1 cells, serving as
the control, emitted the typical bright-green color, character-
istic of living cells, exhibiting an intact cellular morphology.
This, however, changed signicantly when the cells were treated
with 12.5 mM of 5 and 6, as revealed by the yellow uorescence
resulting from the overlapping of light emitted by AO (green)
and EB (red) (Fig. 7B0 and D0). With 25 mM, both compoundsinduced by the new compounds ancistrobonsolines A1 (5) and A2 (6) in
RSC Adv., 2018, 8, 5243–5254 | 5251
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View Article Onlineinduced a dramatic morphological alteration and disintegra-
tion of cellular organelles, leading to total cell death as illus-
trated by the virtually exclusive red stain in Fig. 7(C0 and E0). All
these results suggest that naphthylisoquinoline alkaloids are
promising lead structures for anticancer drug development.
Experimental section
General experimental procedures
UV/Vis spectra were measured with a Shimadzu UV-1800 spec-
trophotometer, IR spectra with a Jasco FT-IR-4600 type A spec-
trometer, and optical rotations with a Jasco P-1020 polarimeter.
ECD spectra were obtained on a J-715 spectropolarimeter (Jasco)
at room temperature, using a standard cell (0.02 cm) and
spectrophotometric-grade methanol, and are reported in D3
values (cm2 mol1) at the given wavelength l (nm). GC-MSD
analyses were performed on a GCMS-QP 2010SE (Shimadzu).
1D and 2D NMR spectra were recorded on Bruker Avance III HD
400 (400 MHz) and 600 (600 MHz) instruments in deuterated
methanol. Chemical shis (d) are reported in parts per million
(ppm) with the 1H and 13C signals of the solvent (1H, d ¼
3.31 ppm; 13C, d ¼ 49.15 ppm) as the internal reference. HRE-
SIMS spectra were obtained on a microTOF-focus and
micrOTOF-Q III mass spectrometers (Bruker). Preparative HPLC
separation was performed on a Jasco HPLC system (PU-2087,
UV-2077, LC-NetII/ADC), using a SymmetryPrep C18 column
(Waters, 19  300 mm, 7 mm) with the UV absorption wave-
lengths set at 232, 254, and 310 nm. Organic solvents were
analytical grade or distilled prior to use.
Plant material
Ancistrocladus plant material, morphologically related to those
of A. likoko, were collected in August 2015 (Global Positioning
System coordinates: 0006.572S, 01820.146E, 315  22 m) by
one of us (B. K. L.) in the vicinity of the village Bonsolerive,
which is located at about 20 km southeast of the town of
Mbandaka in the Democratic Republic of the Congo. A voucher
specimen (No. 105) has been deposited at the Herbarium
Bringmann, Institute of Organic Chemistry, University of
Wu¨rzburg.
Extraction and isolation
Air-dried leaves (200 g) were ground and repeatedly extracted by
maceration with a neutral mixture of MeOH – CH2Cl2 (1 : 1, 2 L)
with mechanical shaking (160 RPM). Aer three cycles of 24 h
each, the ltrates were evaporated to dryness and the marc was
extracted with an acidied (HCl) mixture of MeOH – CH2Cl2
(1 : 1, pH ¼ 2–3, 2 L), again with mechanical shaking, for 48 h.
The acidied extract was neutralized with NaOH and mixed
with the neutral one, aer the similarity between the two
extracts was established by analytical HPLC. The resulting total
crude residue was submitted to a cation-exchange column
(Amberlyst-15 from Fluka, Ø 3 cm) to remove undesired, non-
basic metabolites.21 The obtained alkaloid-enriched fraction
was partitioned between water and dichloromethane, giving,
aer evaporation, 800 mg of an aqueous subfraction and 30 mg5252 | RSC Adv., 2018, 8, 5243–5254of dichloromethane subfraction. The polar subfraction was
dissolved in methanol and resolved by preparative HPLC, using
the following gradient: A/B: 0 min 10% B; 25 min 25% B; 30 min
28% B; 31 min 100% B; 34 min 100% B; 35 min 10% B, in which
A ¼ 90% H2O + 0.05% triuoroacetic acid and B ¼ 90% MeCN +
0.05% triuoroacetic acid. From this subfraction, eight
metabolites were obtained, including the alkaloids 1–3 and 6–
10. Resolution of the lipophilic subfraction by preparative HPLC
yielded compounds 4 and 5.
Michellamine A6 (1). [a]
25
D :35 (c¼ 0.01, MeOH); UV (MeOH)
lmax nm: 200, 228, 263, 302, 311, 316, 331, 333, 344; ECD
(MeOH) cm2 mol1: D3212 29.1, D3247 +15.2, D3297 11.8, D3331
+5.1; IR (ATM): nmax cm
1: 3329, 1672, 1600, 1418, 1359, 1249,
1181, 1138, 1071, 836, 799, 722; HRESIMS: m/z 757.3486 [M +
H]+ (calcd for C46H49N2O8: 757.3483). For
1H and 13C NMR data,
see Table 1.
Michellamine A7 (2). [a]
25
D :41 (c¼ 0.08, MeOH); UV (MeOH)
lmax nm: 203, 229, 263, 302, 311, 316, 331, 333, 345; ECD
(MeOH) cm2 mol1: D3210 26.5, D3243 +23.3, D3300 14.3, D3340
+4.8; IR (ATM): nmax cm
1: 3329, 1672, 1600, 1418, 1359, 1249,
1181, 1138, 1071, 836, 799, 722; HRESIMS: m/z 771.3655 [M +
H]+ (calcd for C47H51N2O8: 771.3640). For
1H and 13C NMR data,
see Table 2.
Michellamine B4 (3). [a]
25
D :25 (c¼ 0.03, MeOH); UV (MeOH)
lmax nm: 201, 229, 264, 302, 311, 316, 330, 333, 343; ECD
(MeOH) cm2 mol1: D3207 +2.0, D3230 5.7, D3316 +1.0, D3353
0.4; IR (ATM): nmax cm1: 3335, 1672, 1617, 1418, 1360, 1251,
1200, 1137, 1072, 837, 800, 722; HRESIMS: m/z 757.3475 [M +
H]+ (calcd for C46H49N2O8: 757.3483). For
1H and 13C NMR data,
see Table 2.
Michellamine B5 (4). [a]
25
D : 32 (c ¼ 0.008, MeOH); UV
(MeOH) lmax nm: 204, 231, 266, 301, 311, 317, 332, 345; ECD
(MeOH) cm2 mol1: D3210 22.0, D3229 8.0, D3237 10.1, D3262
+14.1, D3304 9.0, D3327 6.7, D3350 11.1; IR (ATM): nmax cm1:
3354, 1670, 1625, 1577, 1408, 1354, 1326, 1262, 1199, 1132,
1071, 957, 832, 798, 720; HRESIMS:m/z 769.3484 [M + H]+ (calcd
for C47H49N2O8: 769.3483). For
1H and 13C NMR data, see
Table 2.
Ancistrobonsoline A1 (5). [a]
25
D : +75 (c ¼ 0.01, MeOH); UV
(MeOH) lmax nm: 336, 325, 315, 312, 236;ECD (MeOH) cm
2
mol1: D3211 10.1, D3229 + 5.7, D3244 2.9, D3269 +0.6, D3281
+0.5, D3320 +2.8; IR (ATM): nmax cm
1: 3382, 1671, 1625, 1575,
1400, 1352, 1326, 1297, 1264, 1198, 1132, 1084, 956, 832, 799,
720; HRESIMS: m/z: 392.1843 [M + H]+ (calcd for C24H26NO4:
392.1856). For 1H and 13C NMR data, see Table 1.
Ancistrobonsoline A2 (6). [a]
25
D : +56 (c ¼ 0.009, MeOH); UV
(MeOH) lmax nm: 336, 325, 315, 313, 237; ECD (MeOH) cm
2
mol1: D3210 12.1, D3229 +4.7, D3242 1.9, D3262 +1.6, D3286
+0.6, D3314 +2.6; IR (ATM): nmax cm
1: 3384, 1670, 1626, 1577,
1457, 1263, 1200, 1130, 1084, 1052, 956, 834, 798, 719; HRE-
SIMS: m/z: 406.2013 [M + H]+ (calcd for C25H28NO4: 406.2013).
For 1H and 13C NMR data, see Table 1.
Known alkaloids isolated, 7–10. The likewise isolated mono-
and dimeric alkaloids, ancistroealaine C (7), korupensamines A
(8a) and B (8b), and michellamines A2 (9) and E (10) were found
to be identical in their spectroscopic, physical, and/or chro-
matographic properties with data previously reported.7–10This journal is © The Royal Society of Chemistry 2018
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View Article OnlineRuthenium-mediated oxidative degradation
Following a procedure described earlier,14 ca. 0.8 mg of the
compounds 1–10 were submitted to a ruthenium(III)-catalyzed
periodate oxidation, followed by derivatization of the resulting
amino acids with MeOH/HCl and (R)-a-methoxy-a-tri-
uoromethylphenylacetyl chloride [(R)-MTPA-Cl, prepared from
(S)-MTPA] and analyzed by GC-MSD.Antiprotozoal activities
The assessment of the antiprotozoal properties of the
compounds 5 and 6 against Plasmodium falciparum (NF54 and
K1), Trypanosoma cruzi (Tulahuen C2C4 with the Lac Z gene
incorporated) amastigotes in mouse macrophages, Trypano-
soma brucei rhodesiense (STIB900) bloodstream stages, and
Leishmania donovani (MHOM/ET/67/L82) axenic amastigotes
and the testing of the cytotoxicity against mammalian host cells
(rat skeletal myoblast L6 cells) were done in vitro as previously
described.33Cytotoxicity assay
The cytotoxicity assays against HeLa cell line (RCB0007, Tsu-
kuba, Japan) were carried out as described previously.24 In brief,
exponentially growing cells were harvested and plated in 96-well
plates (2 103 per well) in DMEM and allowed to attach for 24 h
in the humidied CO2 incubator at 37 C. The cells were then
washed with phosphate-buﬀered saline (PBS) followed by the
addition of serially diluted test samples in DMEM. For each
concentration, three replications were performed. Aer 72 h of
incubation, the cells were washed twice with PBS, and 100 mL of
DMEM containing 10% WST-8 cell counting kit (Dojindo
Molecular Technologies, Inc., Rockville, MD, USA) solution
were added. Aer 3 h of incubation, the absorbance at 450 nm
was measured on an EnSpire Multimode plate reader (Perki-
nElmer, Inc., Waltham, MA, USA). Cell viability was calculated
from the mean values from three wells using the following
equation:
Cell viability (%) ¼ [(Abstest sample  Absblank)/
(Abscontrol  Absblank)]  100%
Antiausterity assay
The human pancreatic cancer PANC-1 (RBRC-RCB2095, Tsu-
kuba, Japan) cell line was purchased from the Riken BRC cell
bank and maintained in the standard DMEM with 10% FBS
supplement under a humidied atmosphere of 5% CO2 in the
incubator at 37 C. For the antiausterity evaluation, exponen-
tially growing cells were seeded in 96-well plates (1.5  104 per
well) in DMEM and incubated for 24 h for the cell attachment.
Aer this incubation time, the cells were washed twice with PBS,
the medium was changed to serially diluted test samples in
both nutrient-rich medium (DMEM) and nutrient-deprived
medium (NDM) with a control and a blank in each test plate.
The composition of the NDM was as follows: 0.1 mg L1
Fe(NO3)3 (9H2O), 265 mg L
1 CaCl2 (2H2O), 400 mg L
1 KCl,This journal is © The Royal Society of Chemistry 2018200 mg L1 MgSO4 (7H2O), 6400 mg L
1 NaCl, 700 mg L1
NaHCO3, 125 mg L
1 NaH2PO4, 15 mg L
1 phenol red,
25 mM L1 HEPES buﬀer (pH 7.4), and MEM vitamin solution
(Life Technologies, Inc., Rockville, MD, USA); the nal pH was
adjusted to 7.4 with 10% aqueous NaHCO3. Aer 24 h of incu-
bation with the respective test compound in DMEM and NDM,
the cells were washed twice with PBS and replaced by 100 mL of
DMEM containing 10% WST-8 cell counting kit solution. Aer
3 h of incubation, cell viability was measured and calculated as
described above.Morphological assessment of cancer cells
For studies on morphological changes, HeLa and PANC-1 cells
were seeded in 24-well plates (1  105) and incubated in
a humidied CO2 incubator for 24 h for the cell attachment. The
cells were then washed twice with PBS and treated with vehicle
control or test compounds in DMEM for HeLa cells; and vehicle
control or test compounds in NDM for PANC-1 cells, and
incubated for 24 h. For nuclei staining, two drops of the
NucBlue® ready probe (Hoechst 33342) was directly added to
the cells in full media and was incubated for further 25 min at
the end of the experiment. For cellular morphology, 10 mL of EB/
AO reagent (dye mixture: 100 mg mL1 AO and 100 mg mL1 EB
in PBS) was added to each test well and further incubated for
10 min. The cellular images were captured in the uorescent
and phase contrast modes, using an EVOS FL digital micro-
scope (20 objectives).Conclusions
In summary, this paper describes the discovery of the rst
twofold 1,3-cis-congured michellamine-type dimers, 1 and 2,
and of four other mono- and dimeric naphthylisoquinoline
alkaloids, 3–6, in the leaves of an as yet unidentied Congolese
Ancistrocladus liana related to A. likoko. These new compounds,
obtained along with ve previously described analogs, 7–10,
chemotaxonomically delineate this Congolese plant from all
known related taxa, thus suggesting that it is probably a new
species. Further taxonomic investigations, including DNA
analysis, are planned. Some of the isolated metabolites have
shown attractive cytotoxicities against the HeLa cell line and
very good antiausterity activities against PANC-1 human
pancreatic cancer cells. The weak-to-moderate antiprotozoal
properties of the new monomeric metabolites 5 and 6 highlight
the consequence of the stereochemical features on the biolog-
ical activities and provide valuable information for the ongoing
SAR investigations.Conﬂicts of interest
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